Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Jerusalem, Israel
SEC filing record 1 source field available
Fiscal year end
31 December
Scinai Immunotherapeutics Ltd. has filed 482 SEC EDGAR filings since 13 Nov 2014

SEC filing history

Showing 151-175 of 482 matching filings.

Per page
25
Current page
7
6-K File 001-37353

REPORT OF FOREIGN PRIVATE ISSUER

Filing date
03 Jul 2023
Reporting date
03 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-37353

REPORT OF FOREIGN PRIVATE ISSUER

Filing date
03 Jul 2023
Reporting date
03 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37353

CURRENT REPORT

Filing date
08 Jun 2023
Reporting date
04 Jun 2023
Next action
Verify source filing
10-Q File 001-37353

QUARTERLY REPORT

Filing date
15 May 2023
Reporting date
31 Mar 2023
Next action
Verify source filing
8-K File 001-37353

CURRENT REPORT

Filing date
11 May 2023
Reporting date
10 May 2023
Next action
Verify source filing
8-K File 001-37353

CURRENT REPORT

Filing date
04 May 2023
Reporting date
01 May 2023
Next action
Verify source filing
8-K File 001-37353

CURRENT REPORT

Filing date
04 May 2023
Reporting date
04 May 2023
Next action
Verify source filing
S-8 File 333-271293

REGISTRATION STATEMENT

Filing date
17 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-37353

ANNUAL REPORT

Filing date
17 Apr 2023
Reporting date
31 Dec 2022
Next action
Verify source filing
NT 10-K File 001-37353

NOTIFICATION OF LATE FILING

Filing date
03 Apr 2023
Reporting date
31 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89384

NONE

Filing date
06 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-37353

REPORT OF FOREIGN PRIVATE ISSUER

Filing date
23 Jan 2023
Reporting date
23 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3/A

3/A filing

Filing date
23 Jan 2023
Reporting date
01 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3/A

3/A filing

Filing date
23 Jan 2023
Reporting date
01 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3/A

3/A filing

Filing date
23 Jan 2023
Reporting date
01 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3/A

3/A filing

Filing date
23 Jan 2023
Reporting date
01 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-37353

REPORT OF FOREIGN PRIVATE ISSUER

Filing date
11 Jan 2023
Reporting date
11 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-37353

REPORT OF FOREIGN PRIVATE ISSUER

Filing date
09 Jan 2023
Reporting date
09 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
05 Jan 2023
Reporting date
01 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-37353

REPORT OF FOREIGN PRIVATE ISSUER

Filing date
04 Jan 2023
Reporting date
04 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89384

SABBY 13G BVXV 1.04.23

Filing date
04 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
03 Jan 2023
Reporting date
01 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
03 Jan 2023
Reporting date
01 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
03 Jan 2023
Reporting date
01 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
03 Jan 2023
Reporting date
01 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .